Search
01/04/2026
Rheumatologists' perceptions of biosimilar use in Spain: the CUSTODIAN study
Corominas, H, Guigini, MA, Ameruso, YS, Reina, D. Rheumatologists' perceptions of biosimilar use in Spain: the CUSTODIAN study. CURRENT MEDICAL RESEARCH AND OPINION. 2026; 42(2)DOI:10.1080/03007995.2026.2656544. PMID:42030169. IF:2.200(Q2/3D).
01/04/2026
Early care limitation after ICH in a population-based study: what drives clinicians' decisions?
Lambea-Gil, A, Camps-Renom, P, Martí-Fàbregas, J, Guasch-Jiménez, M, Ezcurra-Díaz, G, Fernández-Vidal, JM, Prats-Sanchez, L, Martínez-Domeño, A, de la Ossa, NP, Ramos-Pachón, A. Early care limitation after ICH in a population-based study: what drives clinicians' decisions?. European Stroke Journal. 2026; 11(4)DOI:10.1093/esj/aakag028. PMID:41947561. IF:4.500(Q1/2D).
01/04/2026
Biomarkers for advancing diagnosis and prognosis in stroke
Tiedt, S, Bustamante, A, Cameron, A, Camps-Renom, P, Grosse, GM, Ospel, J, Volbers, B, Audebert, HJ, Aulin, J, Cheng, BS, Cordonnier, C, Coutinho, JM, Fonseca, AC, Hill, MD, Jensen, M, Jern, C, Kamtchum-Tatuene, J, Katan, M, Kelly, PJ, Kopczak, A, Lemmens, R, Lindgren, AG, Loan, JJM, Nolte, CH, Puy, L, Saba, L, Salman, RA, Sandset, EC, Selim, MH, Seners, P, Sprigg, N, Tsai, HH, Doyle, KM, Montaner, J, Schreuder, FHBM, Sposato, L, Samarasekera, N, Mccabe, JJ. Biomarkers for advancing diagnosis and prognosis in stroke. LANCET NEUROLOGY. 2026; 25(4)DOI:10.1016/S1474-4422(25)00480-6. PMID:41864237. IF:45.500(Q1/1D).
01/04/2026
Two exploratory studies to investigate the role of self and emotional dysregulation in borderline personality disorder
Soler, J, Borao, L, Schmidt, C, Martinez-Rubio, D, Cebolla, A, Montero-Marin, J, García-Campayo, J, Gascon-Santos, S, Pascual, JC. Two exploratory studies to investigate the role of self and emotional dysregulation in borderline personality disorder. EUROPEAN JOURNAL OF PSYCHIATRY. 2026; 40(2)DOI:10.1016/j.ejpsy.2026.100347. PMID:. IF:1.500(Q3/7D).
01/04/2026
Compulsive sexual behavior in cocaine use disorder: Treatment outcomes and clinical challenges
Palazón-Llecha, A, Trujols, J, Madre, M, Duran-Sindreu, S, Batlle, F, Mallorquí-Bagué, N. Compulsive sexual behavior in cocaine use disorder: Treatment outcomes and clinical challenges. ACTA PSYCHOLOGICA. 2026; 264DOI:10.1016/j.actpsy.2026.106574. PMID:41812393. IF:2.700(Q2/3D).
01/04/2026
Final clinical data of a phase 1 dose-escalation study of WVT078, a BCMA×CD3 bispecific antibody, alone and in combination with ?-secretase inhibitor WHG626 in patients with relapsed and/or refractory multiple myeloma
Schjesvold, F, Spencer, A, Cohen, YC, Ocio, EM, Lopez-Pardo, J, Cafro, AM, Callander, NS, Kaufman, JL, Mohan, M, Wermke, M, Doki, N, Kan, RBC, Milanez-Almeida, P, Stein, A, Trabucco, G, Ye, S, Kulec, K, Sechaud, R, Banerjee, S, Zhong, HQ, Lai, CT, Rauch, PJ, Raab, MS. Final clinical data of a phase 1 dose-escalation study of WVT078, a BCMA×CD3 bispecific antibody, alone and in combination with ?-secretase inhibitor WHG626 in patients with relapsed and/or refractory multiple myeloma. CANCER. 2026; 132(7)DOI:10.1002/cncr.70341. PMID:41880322. IF:5.100(Q1/3D).
01/04/2026
Evolving Patterns of EBV-Associated PTLD After Allogeneic Stem Cell Transplantation: Frequency, Characteristics and Outcomes in a Multicenter GETH-TC Study
García-Cadenas, I, Guerreiro, M, Yañez, L, Chorao, P, Martin, F, Suárez-Lledó, M, Pérez, A, Tomás, LG, López, J, Marsal, J, Romero, N, Huguet, M, Zabalza, A, González-Vicent, M, Vázquez, L, Silva, P, Gil, D, Micó-Cerdà, M, Sánchez, P, Filaferro, S, Balsalobre, P, Jiménez-Ubieto, A, Martino, R, Piñana, JL. Evolving Patterns of EBV-Associated PTLD After Allogeneic Stem Cell Transplantation: Frequency, Characteristics and Outcomes in a Multicenter GETH-TC Study. EUROPEAN JOURNAL OF HAEMATOLOGY. 2026; 116(4)DOI:10.1111/ejh.70109. PMID:41502050. IF:2.300(Q2/5D).
01/04/2026
Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study
Mikulska, M, Tridello, G, Ljungman, P, Styczynski, J, Averbuch, D, Cesaro, S, Knelange, N, Wendel, L, Piñana, JL, Popova, M, Kröger, N, Sengeloev, H, Besley, C, Labussiere-Wallet, H, Yegin, ZA, Greco, R, Baron, F, Yonal-Hindilerden, I, Xhaard, A, Metafuni, E, Verbeek, M, Byrne, J, Toprak, SK, Grassi, A, Vallisa, D, Clay, J, Bufarull, RM, Van Gorkom, G, Sevindik, OG, Wilson, K, de la Camara, R. Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study. BONE MARROW TRANSPLANTATION. 2026; 61(4)DOI:10.1038/s41409-026-02819-y. PMID:41795056. IF:5.200(Q1/1D).
01/04/2026
Assessing the Value Contribution of Vyvgart® (Efgartigimod Alfa) in the Treatment of Generalized Myasthenia Gravis with Acetylcholine Receptor Antibody in Spain Through Multi-criteria Decision Analysis
Cortés-Vicente, E, Guerrero, A, Díaz, C, Martínez, E, Toja-Camba, FJ, Abad, MR, Serra, JM, Trillo, JL, Machín, CM, Gil, A. Assessing the Value Contribution of Vyvgart® (Efgartigimod Alfa) in the Treatment of Generalized Myasthenia Gravis with Acetylcholine Receptor Antibody in Spain Through Multi-criteria Decision Analysis. ADVANCES IN THERAPY. 2026; 43(4)DOI:10.1007/s12325-026-03490-x. PMID:41591648. IF:4.000(Q1/3D).
01/04/2026
Clinical Heterogeneity and Candidate Biomarkers in POLG-Related Mitochondrial Disease
Bermejo-Guerrero, L, Restrepo-Vera, JL, Martin-Jimenez, P, Navarro-Riquelme, M, Garrido-Moraga, R, Ochoa, LE, González-Quintana, A, Hernandez-Lain, A, Castillo-Villalba, J, Morís, G, Muelas, N, García-Arumí, E, González, V, Martínez-Sáez, E, Vesperinas, A, Llansó, L, Juntas-Morales, R, Paradas, C, Kapetanovic, S, Blázquez, A, Martí, R, Arenas, J, Martín, MA, Domínguez-González, C. Clinical Heterogeneity and Candidate Biomarkers in POLG-Related Mitochondrial Disease. Neurology-Genetics. 2026; 12(2)DOI:10.1212/NXG.0000000000200365. PMID:41822038. IF:3.700(Q1/3D).
01/04/2026
Myasthenia gravis in Spain: A survey of specialized neurologists to uncover unmet needs
Cortés-Vicente, E, Casasnovas, C, Juntas, R, Sevilla, T, Pardo, J, de Rivera, FR, Sola, AG. Myasthenia gravis in Spain: A survey of specialized neurologists to uncover unmet needs. NEUROLOGIA. 2026; 41(3)DOI:10.1016/j.nrl.2025.501912. PMID:. IF:3.100(Q2/4D).
01/04/2026
Fulzerasib plus cetuximab in first-line KRASG12C-mutated nonsmall-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial
Gregorc, V, Majem, M, Lo Russo, G, Maio, M, Salvagni, S, Gutiérrez-Calderon, V, Gonzalez-Cao, M, Contreras, SS, Koumarianou, A, Bearz, A, Bernabé-Caro, R, Viteri, S, de Sanmamed, MF, Zagouri, F, Bueno, TM, Lazzari, C, Martínez-Recio, S, Giménez-Capitán, A, Zhang, Y, Shan, Y, Zhu, HQ, Zhao, CQ, Shen, HG, Wang, Y, Rosell, R. Fulzerasib plus cetuximab in first-line KRASG12C-mutated nonsmall-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial. LANCET ONCOLOGY. 2026; 27(4)DOI:10.1016/S1470-2045(25)00764-8. PMID:41926959. IF:35.900(Q1/1D).
01/04/2026
Identification of prognostic variables in patients with recurrent head and neck squamous cell carcinoma treated with salvage surgery: Implications for treatment with immunotherapy
Holgado, A, Llansana, A, Vázquez, C, Gallego, O, Aguado, M, Valero, C, León, X. Identification of prognostic variables in patients with recurrent head and neck squamous cell carcinoma treated with salvage surgery: Implications for treatment with immunotherapy. ORAL ONCOLOGY. 2026; 175DOI:10.1016/j.oraloncology.2026.107903. PMID:41722172. IF:3.900(Q1/2D).
01/04/2026
Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients
Ganoza, CA, Westenberger, A, Paul, JJ, Curado, F, Rennecke, J, Mannepalli, S, Zonic, E, Saravanakumar, D, Paknia, O, Al-Ali, R, Laabs, B, Csoti, I, Valzania, F, Vandenberghe, W, Reetz, K, Afshari, M, Hassin-Baer, S, Fonoff, ET, Gruber, D, de Rosa, A, Musacchio, T, Aguiar, PD, Negrotti, A, Tumas, V, Gomez-Esteban, JC, Gurevich, T, Pavese, N, Kulisevsky, J, Sammler, E, Klein, C, Bauer, P, Beetz, C. Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients. MOVEMENT DISORDERS. 2026; 41(4)DOI:10.1002/mds.70161. PMID:41439479. IF:7.600(Q1/1D).
01/04/2026
Geographical Differences in the Epidemiology and Treatment of Candida Prosthetic Joint Infections
Mamona-Kilu, C, Lora-Tamayo, J, McNally, M, Duran, C, Ho, RSMY, Scarborough, M, Dudareva, M, Bonnet, E, Escolà-Vergé, L, Pardo, DR, Jesuthasan, G, Senneville, E, Thill, P, Klein, S, Ronde-Oustau, C, Redó, MLS, Corvec, S, Rossi, N, Esteban, J, Lemaignen, A, Ribeiro, TC, Mazet, J, Sasso, M, Salles, MJC, Mancheño-Losa, M, Giordano, G, Frank, BJH, Hofstaetter, JG, Allende, JMB, Lortholary, O, Fourcade, C, Morata, L, Soriano, A, Dinh, A. Geographical Differences in the Epidemiology and Treatment of Candida Prosthetic Joint Infections. Open Forum Infectious Diseases. 2026; 13(4)DOI:10.1093/ofid/ofag208. PMID:41988413. IF:3.800(Q1/3D).
01/04/2026
Combining Airway Clearance Techniques and Inhaled Antibiotics in Chronic Bronchial Infection: Real-World Evidence of Exacerbation Reduction (INBREATHING Study)
Monge, A, Martinez-De las Fuentes, AM, Burgos, J, Pou, C, Lakhani, JS, Navarro, A, Castanon, RA, Garcia-Urrestarazu, EJ, Sayés, A, Alcaide, AB, Erro, M, Moreno, BR, Sánchez-Cucó, A, Santisteve, S, Benitez, ID, Moncusi-Moix, A, Gracia-Lavedan, E, Manzano, C, Morales, A, Barbé, F, Suarez-Cuartin, G, de la Rosa-Carrillo, D, de-Torres, JP, González, J. Combining Airway Clearance Techniques and Inhaled Antibiotics in Chronic Bronchial Infection: Real-World Evidence of Exacerbation Reduction (INBREATHING Study). ARCHIVOS DE BRONCONEUMOLOGIA. 2026; 62(4)DOI:10.1016/j.arbres.2025.10.017. PMID:41253672. IF:9.200(Q1/1D).
01/04/2026
Influence of the level of education on cognitive function in Parkinson's disease
Santos-García, D, Fonticoba, TD, Bartolomé, CC, Alvarado, MCI, Samaniego, L, Maside, AL, Gallego, L, Barreiro, LC, Caramés, JR, Painceiras, MJF, González, JMP, Jesús, S, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, García-Soto, JD, Borrué, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Mendoza, Z, Pareés, I, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Seijo, M, Valero, C, Redondo, RA, Buongiorno, MT, Ordás, C, Menéndez-González, M, Mcafee, D, Martinez-Martin, P, Mir, P. Influence of the level of education on cognitive function in Parkinson's disease. JOURNAL OF NEURAL TRANSMISSION. 2026; 133(4)DOI:10.1007/s00702-025-03074-z. PMID:41428073. IF:4.000(Q1/2D).
01/04/2026
Declining 28-day population myocardial infarction case-fatality trends in Catalonia, Spain: an analysis of the possible contribution of emergency management network
Tizón-Marcos, H, Camps-Vilaró, A, Roman-Dégano, I, Subirana, I, Cainzos-Achirica, M, Puig, T, Mauri, J, Lidon, RM, Arbelo, E, Marrugat, J. Declining 28-day population myocardial infarction case-fatality trends in Catalonia, Spain: an analysis of the possible contribution of emergency management network. EUROPEAN JOURNAL OF PUBLIC HEALTH. 2026; 36(2)DOI:10.1093/eurpub/ckaf203. PMID:41477688. IF:3.900(Q1/2D).
01/04/2026
New GRADE Evidence-to-Decision Framework for Pairwise and Multiple Comparisons (GRADE Guidance 45)
Beltran, J, Etxeandia-Ikobaltzeta, I, Piggott, T, Akl, EA, Mustafa, RA, Hazlewood, G, Canelo-Aybar, C, Santesso, N, Brignardello-Petersen, R, Mathioudakis, AG, Carrasco-Labra, A, Nonino, F, De Beer, H, Mayer, M, Shamliyan, T, Wiercioch, W, Dietl, B, Guyatt, G, Schünemann, HJ, Alonso-Coello, P. New GRADE Evidence-to-Decision Framework for Pairwise and Multiple Comparisons (GRADE Guidance 45). ANNALS OF INTERNAL MEDICINE. 2026; 179(4)DOI:10.7326/ANNALS-25-04273. PMID:41839032. IF:15.200(Q1/1D).
01/04/2026
Conversational AI for remote monitoring in heart failure: a prospective controlled pilot study
Olivella, A, Fernández, ABM, García, EG, Torregimeno, AO, Ródenas-Alesina, E, López, RA, Pelaez, TM, Soriano-Colomé, T, Avilés, AS, Uribarri, A, Sánchez, TS, Bocanegra, CP, Baldrich, ED, Martinez-Zapata, MJ, Rubio-Valera, M, Ferreira-González, I. Conversational AI for remote monitoring in heart failure: a prospective controlled pilot study. European Heart Journal - Digital Health. 2026; 7(3)DOI:10.1093/ehjdh/ztag032. PMID:41815105. IF:(Q/D).